No profile data available.
Contineum Therapeutics, Inc. (CTNM) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in San Diego, United States, with about 41 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$59.98 million. Its market capitalization was $320.42 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States.
Contineum Therapeutics reported $0 in revenue for fiscal year 2025.
$320.42 million as of December 4, 2025.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Nika Pharmaceuticals, INC (NIKA), Emergent BioSolutions Inc. (EBS), Silence Therapeutics plc (SLN), Probi AB (publ) (PBBIF).